Fludarabine Plus Octreotide in Treating Patients With Relapsed Low-Grade Non-Hodgkin's Lymphoma

NCT00002779 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

34

Enrollment

OTHER

Sponsor class

Conditions

Lymphoma

Interventions

DRUG: fludarabine phosphate
DRUG: octreotide acetate

Sponsor

Alliance for Clinical Trials in Oncology

Collaborators

[object Object]